Your browser doesn't support javascript.
loading
The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.
Monto, Arnold S; Zambon, Maria; Weir, Jerry P.
Affiliation
  • Monto AS; From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).
  • Zambon M; From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).
  • Weir JP; From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).
N Engl J Med ; 390(14): 1256-1258, 2024 Apr 11.
Article in En | MEDLINE | ID: mdl-38416423

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza B virus / Influenza Vaccines / Influenza, Human Limits: Humans Language: En Journal: N Engl J Med / N. Engl. j. med / New England journal of medicine Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza B virus / Influenza Vaccines / Influenza, Human Limits: Humans Language: En Journal: N Engl J Med / N. Engl. j. med / New England journal of medicine Year: 2024 Document type: Article Country of publication: